Ming‐Che Lee
Impact in
- Transplantation top 5%
- Renal Transplantation Outcomes and Treatments
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
Papers in
-
- Renal Transplantation Outcomes and Treatments 9
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Co-authors
- Bang‐Gee Hsu (28 shared papers)Wen‐Sheng Wu (9 shared papers)Tomohiro Ishii (3 shared papers)Eishi Totsuka (3 shared papers)John J. Fung (3 shared papers)Ren-In You (7 shared papers)Teng‐Yi Lin (9 shared papers)Chuan-Chu Cheng (7 shared papers)
- Journals
- PLoS ONE (3 papers)Clinical Transplantation (3 papers)Diabetes & Metabolism (2 papers)Regulatory Peptides (2 papers)European Respiratory Journal (2 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Ming‐Che Lee
105 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 105
- Transplantation 50
- Infectious Diseases 182
- Endocrinology 36
- Nephrology 82
- Surgery 321
Countries citing papers authored by Ming‐Che Lee
This map shows the geographic impact of Ming‐Che Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Che Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Che Lee more than expected).
Fields of papers citing papers by Ming‐Che Lee
This network shows the impact of papers produced by Ming‐Che Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Che Lee. The network helps show where Ming‐Che Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming‐Che Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 110 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 133 | |
| 2 | 2004 | 90 | |
| 3 | 2013 | 76 | |
| 4 | 2017 | 75 | |
| 5 | 2002 | 55 | |
| 6 | 2020 | 50 | |
| 7 | 2014 | 45 | |
| 8 | Oral bacterial therapy promotes recovery from acute diarrhea in children. | 2001 | 44 |
| 9 | 2011 | 42 | |
| 10 | 2016 | 38 | |
| 11 | 2008 | 37 | |
| 12 | 2011 | 37 | |
| 13 | 2020 | 33 | |
| 14 | 2012 | 29 | |
| 15 | 2007 | 27 | |
| 16 | 2014 | 26 | |
| 17 | 2014 | 25 | |
| 18 | 2020 | 25 | |
| 19 | 2001 | 24 | |
| 20 | 2015 | 24 |
About Ming‐Che Lee
Ming‐Che Lee is a scholar working on Transplantation, Hepatology, Cardiology and Cardiovascular Medicine, Infectious Diseases and Surgery, having authored 110 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cardiovascular Health and Disease Prevention (12 papers), Renal Transplantation Outcomes and Treatments (9 papers), Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Tuberculosis Research and Epidemiology (6 papers), Adipokines, Inflammation, and Metabolic Diseases (6 papers), Polyomavirus and related diseases (6 papers), Bone health and osteoporosis research (4 papers) and Intraperitoneal and Appendiceal Malignancies (4 papers). The work is most often cited by research in Transplantation (50 citations), Infectious Diseases (182 citations), Endocrinology (36 citations), Nephrology (82 citations) and Surgery (321 citations). Ming‐Che Lee has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Bang‐Gee Hsu, Wen‐Sheng Wu, Tomohiro Ishii, Eishi Totsuka, John J. Fung, Ren-In You, Teng‐Yi Lin, Chuan-Chu Cheng, Chung‐Jen Lee and Jorge Gutierrez. Their work appears in journals such as PLoS ONE, Clinical Transplantation, Diabetes & Metabolism, Regulatory Peptides and European Respiratory Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.